Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Elizabeth Juneman
Associate Professor, Medicine - (Clinical Scholar Track)
Medicine
Overview
Research
More
Collaboration
(27)
Lee Ryan
Mutual work: 1 Grant
Collaboration Details
Kacey Ernst
Mutual work: 1 Grant
Collaboration Details
Bonnie LaFleur
Mutual work: 1 Grant
Collaboration Details
Sairam Parthasarathy
Mutual work: 1 Grant
Collaboration Details
Vignesh Subbian
Mutual work: 1 Grant
Collaboration Details
Page 1 of 6
Previous page
Next page
Grants
(24)
NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults (Initiative: REsearching COVid to Enhance Recovery (RECOVER) Initiative)
Active
·
2021
·
$241.8K / $12.1M
·
External
Co-Investigator (COI)
post-acute sequelae,
sars-cov-2 infection,
adults,
recovery initiative
An Exploratory, Open-label, Proof Of Concept, Phase 2a Study Of Mavacamten (MYK461) In Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Chronic Elevation Of Cardiac Troponi
Active
·
2021
·
$251.5K
·
External
Principal Investigator (PI)
heart failure,
cardiac troponin i,
mavacamten,
ejection fraction
A Randomized, Double-Blind, Placebo-controlled, Single-ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of JK07 in Subjects with Heart Failure with Reduced Ejection Fra...
Active
·
2020
·
$606.2K
·
External
Principal Investigator (PI)
pharmacokinetics,
heart failure,
safety,
tolerability,
clinical trial
Precision Medicine for Dilated Cardiomyopathy - Cardiac Magnetic Resonance to Identify Early Family Phenotypes
Active
·
2020
·
$33.2K
·
External
Principal Investigator (PI)
precision medicine,
dilated cardiomyopathy,
cardiac magnetic resonance,
identify early,
family phenotypes
Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Injection Fraction (ANTHEM-HFrEF)
Active
·
2018
·
$413.9K
·
External
Principal Investigator (PI)
autonomic regulation therapy,
myocardial function,
heart failure,
injection fraction,
research therapy
Page 1 of 5
Previous page
Next page
Publications
(51)
Recent
Aortic valve disorders and left ventricular assist devices
2023
Global Variations in Heart Failure Etiology, Management, and Outcomes
2023
Steroid-Responsive Fulminant Lymphocytic Myocarditis Mimicking Giant-Cell Myocarditis
2023
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction REDUCE LAP-HF II) a randomised, multicentre, blinded, sham-controlled trial
2022
The Relationshibetween Rate and Volume of Intravenous Fluid Administration and Kidney Outcomes after Angiography
2022
Progression of infarct-mediated arrhythmogenesis in a rodent model of heart failure
2021
cardiac arrhythmias,
myocardial infarction,
heart failure,
animal models,
disease progression
IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias
2021
sickle cell,
cardiomyopathy,
il-18,
ventricular arrhythmias,
mediation
Localized Ventricular effective Refractory period Prolongation with an Epicardial Biomaterial
2021
cardiology,
biomaterials,
electrophysiology,
medical devices,
tissue engineering
Orthotopic Heart Transplant Recipient with Enteric-coated Mycophenolate Sodium Myfortic) Induced Colitis
2020
Leading the Compassionate Charge
2020